TDS Pharm Co (XKRX:464280) Interest Coverage : 4.89 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. TDS Pharm Co's Operating Income for the three months ended in Dec. 2024 was ₩297 Mil. TDS Pharm Co's Interest Expense for the three months ended in Dec. 2024 was ₩-61 Mil. TDS Pharm Co's interest coverage for the quarter that ended in Dec. 2024 was 4.89. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for TDS Pharm Co's Interest Coverage or its related term are showing as below:

XKRX:464280' s Interest Coverage Range Over the Past 10 Years
Min: 10.06 Med: 16.64 Max: 17.86
Current: 15.57

XKRX:464280's Interest Coverage is ranked better than
55.12% of 664 companies
in the Drug Manufacturers industry
Industry Median: 11.775 vs XKRX:464280: 15.57

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TDS Pharm Co Interest Coverage Historical Data

The historical data trend for TDS Pharm Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TDS Pharm Co Interest Coverage Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Coverage

10.06

17.86

17.13

16.64

13.93

TDS Pharm Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Interest Coverage	Get a 7-Day Free Trial				No Debt	20.70	12.85	N/A	4.89

Competitive Comparison of TDS Pharm Co's Interest Coverage

For the Drug Manufacturers - General subindustry, TDS Pharm Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TDS Pharm Co's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where TDS Pharm Co's Interest Coverage falls into.

Save Embed

;

Save Embed

;

TDS Pharm Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TDS Pharm Co's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, TDS Pharm Co's Interest Expense was ₩-268 Mil. Its Operating Income was ₩3,730 Mil. And its Long-Term Debt & Capital Lease Obligation was ₩72 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2024 )	/	Interest Expense (A: Dec. 2024 )
	=	-1	*	3729.664	/	-267.688
	=	13.93

TDS Pharm Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the three months ended in Dec. 2024, TDS Pharm Co's Interest Expense was ₩-61 Mil. Its Operating Income was ₩297 Mil. And its Long-Term Debt & Capital Lease Obligation was ₩72 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	297.283	/	-60.748
	=	4.89

The higher the ratio, the stronger the company's Financial Strength is.

TDS Pharm Co (XKRX:464280) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

TDS Pharm Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines